Creators of the First Breath Device to Receive Any Level of FDA Authorization

FDA EUA GRANTED 4/14/2022 – EUA202006

READ MORE ABOUT US

Our Mission

Why Breath?

Research Products

Research Services

Statistics

A Very Different Look at Medical Screening & Diagnostics

InspectIR’s PNY-1000 system is the only respiratory test that brings lab caliber analytics right into the field. With over 99% sensitivity, InspectIR delivers results that usually take days, in minutes.

Our patented system also requires no storage of biological material, cutting down on waste, and the chances for cross infection.

What makes us different:

  • Chemical-lab-in-a-box: we are analyzing breath via mass spectrometry.
  • InspectIR is the first company to produce a commercially available miniature mass spectrometer to analyze breath samples directly.
LEARN MORE ABOUT THE TECHNOLOGY

Total Estimated Time to
Test: 3 Mintues

The COVID-19 pandemic has thrown our world into a state of unknown. Like many, InspectIR Systems asked “how can we help?” and began the necessary research. The results have been outstanding.

READ MORE ABOUT US

InspectIR PNY-1000 COVID Testing Demo

Play Video
InspectIR Systems

Leveraging Proven Science to Monitor Health & Wellness Around the World

COLLECT SAMPLE

Subject Exhales through their mouth into a tube connected to a test kit, much like blowing up a balloon.

CHEMISTRY

Chemistry in the subject’s breath is captured on the patented inspector systems device.

ANALYSIS

Patent issued measurement process runs, allowing identify- cation & qualification of COVID-19 markers & spectrometry.

RESULTS

InspectIR systems device analyzes and displays results utilizing proprietary software.

The Numbers Never Lie

InspectIR is the only testing methodology that does not create cross reactivity, which leads to pre-analytical error, based on adding a solvent.

0
Clinical Trial Subjects
0
Sensitivity
0
Minutes - time from sample collection to results
0
number of breathalyzers to receive any level of FDA Authorization

The Numbers Never Lie

InspectIR Featured on c|net
InspectIR Featured on c|net
Farewell, Swabs? How a New COVID Breath Test Gives Results in 3 Minutes A newly authorized breathalyzer test examines exhalations to quickly detect the presence of COVID-19. Learn how it works. On Thursday, the US Food and Drug Administration authorized emergency...
Read More
InspectIR Featured in Yahoo Business
InspectIR Featured in Yahoo Business
This Breath Test Can Detect Whether You Have COVID-19 in Just 3 Minutes Rapid testing for COVID-19 has become part of many Americans’ lives since late 2021, but now, a new COVID-19 breath test might make it even more convenient to get tested. On Thursday, the U.S....
Read More
InspectIR Featured in Forbes Magazine
InspectIR Featured in Forbes Magazine
Meet The Founders Of The $2.7 Million Startup Behind The New Covid Breathalyzer When the first wave of states started to legalize medical and recreational marijuana in the 2010s, Tim Wing and John Redmond envisioned a cannabis breathalyzer that could analyze samples...
Read More
InspectIR Featured in Time Magazine
InspectIR Featured in Time Magazine
The First COVID-19 Breathalyzer Test Is Coming to the U.S. COVID-19 testing has become more convenient and accessible, but with the pandemic still causing more than 30,000 new infections in the U.S. on average each week, having more ways to detect SARS-CoV-2 can go a...
Read More
InspectIR Featured in Dallas Innovates
InspectIR Featured in Dallas Innovates
Frisco-based InspectIR received the FDA emergency use authorization on Friday for its breathalyzer test, which tests for organic compounds associated with COVID-19 in a person's breath. According to a study, the tests are more effective than the rapid antigen tests...
Read More

Our Team Members

Tim C Wing

Co-Founder CEO

John A. Redmond Jr.

Co-Founder President

Dr. Guido Verbeck

Chief Scientist

Luke Keiser

VP, Sales

Best Award

The best Inventions of 2022

Contact InspectIR Systems, Inc.

InspectIR is in rapid growth mode. Interested in learning more? Complete the form below & a member of our team will be in touch shortly,